Albemarle (ALB) Proxy filing summary

Executive summary

• Achieved $5.1B in net sales and $1.1B adjusted EBITDA in 2025, with 7% volume growth and strong cash flow management, including $1.3B in operating cash flow, up 86% year-over-year.

• Exceeded cost and productivity improvement targets, delivering $450M in savings, and completed strategic divestitures for $670M in proceeds to support debt reduction and growth investments.

• Maintained industry leadership through disciplined execution, portfolio optimization, and enhanced financial flexibility, including a $350M customer prepayment and redemption of preferred equity.

• Board and management focused on long-term shareholder value, with confidence in continued success across lithium and bromine businesses.

Voting matters and shareholder proposals

• Shareholders will vote on: election of 10 directors, advisory say-on-pay, ratification of PwC as auditor, Charter amendment to remove supermajority provisions, approval of the 2026 Incentive Plan, and a shareholder proposal on special meeting rights.

• Board recommends FOR all management proposals and AGAINST the shareholder proposal on special meetings, preferring a higher ownership threshold for such rights.

Board of directors and corporate governance

• Board comprises 10 directors (9 independent), with an average age of 65.3 and tenure of 6.9 years; two new independent directors appointed in 2026.

• Annual director elections, robust independence standards, and regular board/committee evaluations.

• Board leadership includes a combined Chair/CEO and a Lead Independent Director, with clear division of responsibilities.

• Shareholder engagement expanded in 2025, with direct outreach to major investors and responsiveness to feedback on governance and compensation.